| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| BlackRock | - | - | - | Detail |
| Casdin Capital | - | - | - | Detail |
| dRx Capital | - | - | - | Detail |
| LifeSci Venture Partners | - | - | - | Detail |
| Lux Capital | - | - | - | Detail |
| Mubadala Capital Ventures | - | - | - | Detail |
| Perceptive Advisors | - | - | - | Detail |
| Pharmaceutical Product Development | - | - | - | Detail |
| Pura Vida Investments | - | - | - | Detail |
| Redmile Group | - | - | - | Detail |
| RS Investments | - | - | - | Detail |
| RTW Investments | - | - | - | Detail |
| Samsara BioCapital | - | - | - | Detail |
| Surveyor Capital | - | - | - | Detail |
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Jan 3, 2019 | Series D | $ 35M | dRx Capital,Glynn Capital Management,etc. | Detail |
| Aug 20, 2020 | Series Unknown | $ 40M | Amgen,Glynn Capital Management,etc. | Detail |
| Oct 20, 2015 | Series A | $ 6.50M | Arthur Iinuma,dRx Capital,etc. | Detail |
| Apr 25, 2017 | Series C | $ 35M | Amgen Ventures,dRx Capital,etc. | Detail |
| Oct 18, 2016 | Series B | $ 31M | Arthur Iinuma,dRx Capital,etc. | Detail |